Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Duron

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of the American Geriatrics Society|August 10, 2021
Reperfusion therapy for acute ischemic stroke in older people: An observational real-life studyJustine Sudre, Laura Venditti, Claire Ancelet, et al.
Physiological Reports|September 29, 2025
Steroid anabolic and catabolic hormones in highly and recreationally trained female athletes across the menstrual cycleKatia Collomp, Carole Castanier, Caroline Teulier, et al.
Frontiers in Aging Neuroscience|March 7, 2019
Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß<sub>1-42</sub>, and Tau Proteins in Elderly Patients With Mild Cognitive ImpairmentEmmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, et al.
Frontiers in Aging Neuroscience|October 18, 2018
Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ<sub>1-42</sub> and Tau Proteins in Elderly Patients With Mild Cognitive ImpairmentEmmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, et al.
Journal of the American Medical Directors Association|November 3, 2020
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics PatientsBastien Genet, Jean-Sébastien Vidal, Adrien Cohen, et al.
BMC Geriatrics|December 13, 2023
Association between low eosinophil count and acute bacterial infection, a prospective study in hospitalized older adultsLéa Mésinèle, Tom Pujol, Nicoletta Brunetti, et al.
Psychological Medicine|October 22, 2020
The olfactory deficits of depressed patients are restored after remission with venlafaxine treatmentRomain Colle, Khalil El Asmar, Céline Verstuyft, et al.
Journal of Alzheimer'S Disease : JAD|September 3, 2016
Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory CentersEloi Magnin, Jean-François Démonet, David Wallon, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2022
Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort StudyValentine Lidou-Renault, Edouard Baudouin, Pauline Courtois-Amiot, et al.
BMJ Open|June 2, 2019
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in FranceEmmanuel Cognat, François Mouton Liger, Anne-Cécile Troussière, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of the American Geriatrics Society|August 10, 2021
Reperfusion therapy for acute ischemic stroke in older people: An observational real-life studyJustine Sudre, Laura Venditti, Claire Ancelet, et al.
Physiological Reports|September 29, 2025
Steroid anabolic and catabolic hormones in highly and recreationally trained female athletes across the menstrual cycleKatia Collomp, Carole Castanier, Caroline Teulier, et al.
Frontiers in Aging Neuroscience|March 7, 2019
Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß<sub>1-42</sub>, and Tau Proteins in Elderly Patients With Mild Cognitive ImpairmentEmmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, et al.
Frontiers in Aging Neuroscience|October 18, 2018
Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ<sub>1-42</sub> and Tau Proteins in Elderly Patients With Mild Cognitive ImpairmentEmmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, et al.
Journal of the American Medical Directors Association|November 3, 2020
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics PatientsBastien Genet, Jean-Sébastien Vidal, Adrien Cohen, et al.
BMC Geriatrics|December 13, 2023
Association between low eosinophil count and acute bacterial infection, a prospective study in hospitalized older adultsLéa Mésinèle, Tom Pujol, Nicoletta Brunetti, et al.
Psychological Medicine|October 22, 2020
The olfactory deficits of depressed patients are restored after remission with venlafaxine treatmentRomain Colle, Khalil El Asmar, Céline Verstuyft, et al.
Journal of Alzheimer'S Disease : JAD|September 3, 2016
Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory CentersEloi Magnin, Jean-François Démonet, David Wallon, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2022
Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort StudyValentine Lidou-Renault, Edouard Baudouin, Pauline Courtois-Amiot, et al.
BMJ Open|June 2, 2019
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in FranceEmmanuel Cognat, François Mouton Liger, Anne-Cécile Troussière, et al.
Pageof 5